Scientists Design a Nanoparticle That May Improve mRNA Cancer Vaccines

Johns Hopkins Medicine scientists have developed a nanoparticle — an extremely tiny biodegradable container — that has the potential to improve the delivery of messenger ribonucleic acid (mRNA)-based vaccines. This new nanoparticle delivery system may improve the way vaccines are given for infectious disease, and it may open a new avenue for treating cancer as well. Read more about the study here.

SEE ALL NEWS

Recent Posts

New Technology: MRI-guided Focused Ultrasound for Prostate Cancer Advances in Breast Cancer Treatment: Insights from Medical Oncologist Jenni Sheng Early Immunotherapy Shows Promising Results in Advanced Basal Cell Carcinoma New NIH-Funded Johns Hopkins Medicine Study Finds High-Risk Individuals Who Have Mild Dilatation of the Pancreatic Duct Have Increased Risk for Pancreatic Cancer Lung Cancer Symptoms Doctors Say Women Should Never Ignore and the Screening Most Skip Targeted Radiation During Surgery Reduces Pancreatic Cancer Recurrence Colorectal Cancer Is Becoming More Common In Young People. Here Are The Signs. Johns Hopkins-Led Study Finds Drugs Approved for Treating Pain Also Reduce Bone Cancer Growth DNA Shed by Colon Cancers May Help Oncologists Personalize Postsurgical Treatment